Search Results: Displaying all items (22)

First Author Title Journal Publication Date
Leung CC. T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts. Respirology (Carlton, Vic.) 2015
Belay M. QuantiFERON-TB gold in-tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study. BMC infectious diseases 2014
Kowada A. Cost effectiveness of interferon-╬│ release assay for TB screening of HIV positive pregnant women in low TB incidence countries. The Journal of infection 2013
Swaminath A. Cost-effectiveness of QuantiFERON Testing Before Initiation of Biological Therapy in Inflammatory Bowel Disease. Inflammatory bowel diseases 2013
Steffen RE. Cost-Effectiveness of Quantiferon®-TB Gold-In-Tube Versus Tuberculin Skin Testing for Contact Screening and Treatment of Latent Tuberculosis Infection in Brazil. PloS one 2013
Kowada A. Cost effectiveness of high resolution computed tomography with interferon-gamma release assay for tuberculosis contact investigation. European journal of radiology 2013
Oxlade O. How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI. PloS one 2013
Kowada A. Cost-effectiveness of interferon-gamma release assay for entry tuberculosis screening in prisons. Epidemiology and infection 2013
Kowada A. Cost effectiveness of the interferon-╬│ release assay for tuberculosis screening of hemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2013
Shah M. QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis. BMC infectious diseases 2012
Riazi S. Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs). Allergy and asthma proceedings : the official journal of regional and state allergy societies 2012
Kowada A. Cost effectiveness of interferon-gamma release assay for school-based tuberculosis screening. Molecular diagnosis & therapy 2012
Nienhaus A. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC health services research 2011
Katsenos S. Use of interferon-gamma release assay for latent tuberculosis infection screening in older adults exposed to tuberculosis in a nursing home. Journal of the American Geriatrics Society 2011
Kowada A. Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations. Molecular diagnosis & therapy 2010
Burgos JL. Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2009
Deuffic-Burban S. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2010
Diel R. Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany. Respiratory medicine 2009
Sohn H. TB diagnostic tests: how do we figure out their costs? Expert review of anti-infective therapy 2009
Boccia D. Tuberculosis infection in Zambia: the association with relative wealth. The American journal of tropical medicine and hygiene 2009
Load More Results